ANRO
Alto Neuroscience Inc.
Latest News for ANRO
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO). Merck &......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK) and Alto Neuroscience, Inc. (ANRO). Merck &......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Alto Neuroscience, Inc. ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Jasper Therapeutics (JSPR), Alto Neuroscience, Inc......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alto Neuroscience, Inc. (ANRO) and Innovative Eyew......
Chardan Capital analyst Keay Nakae maintained a Buy rating on Alto Neuroscience, Inc. yesterday and set a price target of $30.00. Nakae covers the ......
Alto Neuroscience, Inc. ( ($ANRO) ) has shared an announcement. On April 1, 2026, Alto Neuroscience reported topline Phase 2 proof-of-concept data ......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alto Neuroscience, Inc. (ANRO – Research Report) and......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANRO | $21.98 | +3.0% | 189.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |